Diagnostic Test: Biomarker Analysis At Enrolment: 56 Clinical Trials, Page 1 of 6

Hide Studies Not Open or Pending

5

A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Subjects With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression

Condition(s):Solid Tumor, Adult; Solid Tumor; Pancreatic Cancer; Pancreatic Neoplasms; Pancreas Cancer; Non Small Cell Lung Cancer; Non Small Cell Lung Cancer Recurrent; Non-Small Cell Squamous Lung Cancer; NSCLC; NSCLC, Recurrent; Colorectal Cancer; Colorectal Neoplasms; Colorectal Adenocarcinoma; CRC; Colorectal Cancer Metastatic; CancerLast Updated:March 18, 2024Recruiting

6

A Study to Evaluate the Safety and Efficacy of A2B694, a Logic-gated CAR T, in Subjects With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Condition(s):Solid Tumor, Adult; Colorectal Cancer; NSCLC; Non Small Cell Lung Cancer; NSCLC, Recurrent; Non-Small Cell Squamous Lung Cancer; Pancreas Cancer; Pancreatic Neoplasm; Colorectal Adenocarcinoma; CRC; Colon Cancer; Rectal Cancer; Cancer; Ovarian Cancer; Ovarian Neoplasms; Mesothelioma; Mesothelioma, Malignant; Ovary Cancer; Lung Cancer; MESOMLast Updated:March 18, 2024Recruiting

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.